| Literature DB >> 35571944 |
Yuanfang Kong1, Yulong Hu2,3,4, Jieming Li2,3,4, Juntao Cai2,3,4, Yuanhao Qiu3,4,5, Chunhong Dong2,3,4.
Abstract
Rubus chingii Hu has been used as a functional food for a long time. A novel pectin polysaccharide named RCHP-S from R. chingii Hu was structurally identified and explored its anti-inflammatory effect on colitis mice. RCHP-S was composed of mannose, rhamnose, glucuronic acid, galacturonic acid, glucose, galactose, and arabinose. NMR spectroscopy and methylation analysis showed that RCHP-S was mainly composed of HG-type pectin domains but also contains a small amount of RG-I. The anti-inflammatory tests indicated that the mouse macrophage RAW 264.7 cells pretreated with RCHP-S could show a significant inhibitory effect on the mRNA level of iNOS, IL-1β, IL-6, and TNF-α in vitro. Polysaccharide RCHP-S reduced the enteritis symptoms in dextran sulfate sodium (DSS)-induced colitis mice by inhibiting released inflammatory factors. These results indicated that the R. chingii Hu polysaccharide can be used as food additives for the treatment of intestinal inflammation.Entities:
Keywords: Rubus chingii Hu polysaccharide; anti-inflammatory activity; inflammatory bowel disease; separation and purification; structural characterization
Year: 2022 PMID: 35571944 PMCID: PMC9105459 DOI: 10.3389/fnut.2022.868657
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Figure 1HPGPC chromatogram of RCHP-S.
Figure 2Pre-column PMP derivative HPLC of monosaccharide standards (A) and RCHP-S sample (B).
Methylation analysis results of RCHP-S after reduction.
|
|
|
|
|
|
|---|---|---|---|---|
| A | 2,3,6-Me3-Gal | ( → 4)-Gal | 3.8 | 59, 71, 87, 99, 102, 113, 118, 131, 142, 157, 173, 233 |
| B | 2,3,4,6-Me4-Gal | Glc | 0.8 | 59, 71, 87, 102, 118, 129, 145, 161, 162, 190, 205 |
| C | 2,3-Me2-Gal | ( → 4,6)-Gal | 0.9 | 59, 85, 102, 118, 127, 142, 159, 187, 201, 261 |
| D | 3,4-Me2-Rha | ( → 2)-Rha | 1.7 | 57, 71, 89, 100, 115, 130, 131, 190 |
| E | 3-Me-Rha | ( → 2,4)-Rha | 1.1 | 59, 74, 88, 101, 130, 143, 190, 203 |
| F | 2,3-Me2-Ara | ( → 5)-Ara | 0.8 | 59, 71, 87, 102, 118, 129, 189 |
| G | 2,3,5-Me3-Ara | Ara | 0.8 | 59, 71, 87, 102, 118, 129, 145, 162 |
| H | 2,3,6-Me3-Glc | ( → 4)-Glc | – | 59, 71, 87, 99, 102, 113, 118, 129, 131, 142, 159, 233 |
| I | 2,3,6-Me3-Man | ( → 4)-Man | – | 59, 71, 87, 99, 102, 113, 118, 129, 143, 162, 233 |
Figure 3The 1H NMR spectra (A) and 13C NMR spectra (B) of RCHP-S.
Figure 4The (A) COSY, (B) HSQC, and (C) HMBC spectra of RCHP-S.
Figure 5Structure schematic diagram of RCHP-S.
Figure 6Effect of different RCHP-S concentrations on cytokine secretion [(A) iNOS, (B) IL-1β, (C) IL-6, and (D) TNF-α; **p < 0.01, and ***p < 0.001].
Figure 7(A) Establishment model of mouse enteritis, (B) clinical symptoms of colitis (hematochezia) in mice, (C) DAI scores, (D) colon morphology from mice in different groups, and (E) change in colon length. *p < 0.05, **p < 0.01.
Figure 8ELISA measurements of (A) IL-6 and (B) TNF-α levels in colon tissue. *p < 0.05, **p < 0.01.
Figure 9Haematoxylin-eosin (HE) staining of colon among the different groups (200 ×). (A) Control. (B) 4% DSS. (C) 4% DSS+RCHP-S (L). (D) 4% DSS+RCHP-S (H). (E) 4% DSS+SSZ (arrow 1 indicates the accumulation of inflammatory cells; arrow 2 and 3 indicate the loss of crypts; arrow 4 indicates the intact crypts).